Localized Radiation Therapy or Recombinant Interferon Beta and Anti-PD-L1 (Avelumab) With or Without Cellular Adoptive Immunotherapy in Treating Patients With Metastatic Merkel Cell Carcinoma
Conditions: Merkel Cell Polyomavirus Infection; Stage IV Merkel Cell CarcinomaInterventions: Drug: Anti-PD-L1 Monoclonal Antibody Avelumab; Radiation: Radiation Therapy; Biological: Recombinant Interferon Beta; Biological: MCPyV TAg-specific Polyclonal Autologous CD8-positive T Cells; Other: Laboratory Biomarker AnalysisSponsors: Fred Hutchinson Cancer Research Center; EMD Serono; National Cancer Institute (NCI)Not yet recruiting - verified October 2015
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer & Oncology | Carcinoma | Immunotherapy | Merkel Cell Carcinoma | Radiation Therapy | Research